Related Experiment Video
Updated: Mar 31, 2026

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Gut microbiome features and resistome elements associated with colonization and infection with antibiotic-resistance
Maliha Batool1, Stephanie McMahon1,2, Samantha Franklin1,2
1Department of Veterinary Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX, USA.
Abstract:
Infection with antimicrobial-resistant (AR) pathogens is a leading cause of morbidity and mortality among patients with hematological malignancies; however, little is known about the gut microbiome dynamics in acute myeloid leukemia patients and its impact on AR infections (ARI) and/or colonization with AR pathogens (ARC). Longitudinal stool samples collected from 154 patients undergoing induction chemotherapy were analyzed using 16S rRNA sequencing, selective and differential media culturing, MALDI-TOF, and VITEK2 to identify patients with ARC or ARI and to isolate AR infectious and colonizing bacterial strains. Shotgun metagenomic sequencing of baseline stool samples revealed taxa abundances, resistome features, and KEGG pathways associated with AR-events. Baseline observed species were lower in patients with AR-events (p = 0.01). Although several baseline taxa were more abundant in AR-event patients, they were not statistically significant when they were corrected for false discovery. Functional analysis revealed that penicillin and cephalosporin biosynthesis pathways were significantly enriched in patients with ARC. In summary, identifying the baseline microbiome, resistome, and functional pathway biomarkers may forecast an increased risk of ARI and/or ARC, thereby informing antimicrobial treatment strategies in AML patients.
Insights
The gut microbiome in acute myeloid leukemia patients undergoing chemotherapy may predict antimicrobial-resistant infections. Lower baseline microbial diversity and specific functional pathways indicate a higher risk, informing treatment strategies.
Area of Science:
- Microbiology
- Oncology
- Genomics
Background:
- Antimicrobial-resistant (AR) pathogens cause significant morbidity and mortality in hematological malignancies.
- Gut microbiome dynamics in acute myeloid leukemia (AML) patients and their impact on AR infections (ARI) or colonization (ARC) are poorly understood.
Purpose of the Study:
- To investigate the gut microbiome's role in predicting ARI and/or ARC in AML patients undergoing induction chemotherapy.
- To identify baseline microbiome, resistome, and functional pathway biomarkers associated with AR events.
Main Methods:
- Longitudinal stool samples from 154 AML patients were analyzed.
- Methods included 16S rRNA sequencing, culturing, MALDI-TOF, VITEK2, and shotgun metagenomic sequencing.
- Baseline samples were analyzed for taxa abundance, resistome, and KEGG pathways.
Main Results:
- Patients with AR events had lower baseline observed species (p=0.01).
- Penicillin and cephalosporin biosynthesis pathways were significantly enriched in patients with ARC.
- While some baseline taxa were more abundant in AR-event patients, significance was lost after false discovery correction.
Conclusions:
- Baseline gut microbiome features, including diversity and functional pathways, may serve as biomarkers for forecasting ARI and/or ARC risk in AML patients.
- Identifying these biomarkers can inform personalized antimicrobial treatment strategies.
- Further research into microbiome-targeted interventions is warranted.
Related Concept Videos
Development of Antibiotic Resistance
Clinical Significance of Antibiotic Resistance
Functions of the Gut Microbiota
The Oral Microbiota
Mechanism of Antibiotic Resistance in MRSA
Introduction to the Human Microbiota

